Terazosin Capsule
Product Images NDC 63629-5237

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 63629-5237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636295237)

Label for Terazosin 10 mg capsule by Bryant Ranch Prepack. The label compares this product to Hytrin 10 mg capsule and mentions the manufacturer Jubilant Cadista Pharmaceuticals Inc. It includes directions to follow doctors' instructions and to store at room temperature 20-25°C (68-77°F). The package contains 30 capsules.*

FDA Label Image

Label Image (Lbl636296933)

Terazosin HCl 2 mg capsule label by Bryant Ranch Prepack. The label includes storage instructions at room temperature (20-25°C or 68-77°F), lot number 101092, barcode, and a warning to keep drugs out of reach of children. It compares to Hytrin 2 mg capsule and shows packaging for 30 capsules.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin illustrating its molecular components, including aromatic rings, nitrogen atoms, methoxy groups, and a hydrochloride (HCl) component, represented with standard chemical notation.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

A dual chart showing mean changes over three months comparing Terazosin and Placebo. The left graph illustrates the mean change in total symptom score from baseline with Terazosin showing a greater decrease than Placebo. The right graph depicts the mean increase in peak flow rate from baseline, with Terazosin showing a higher increase compared to Placebo. Sample sizes for each group are also indicated.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line graph showing mean change from baseline over 30 months. The x-axis represents time in months, and the y-axis shows the mean change from baseline with values decreasing from 0 to -7. Data points are connected by a line, with some points marked by asterisks indicating statistical significance. The trend shows a rapid decrease initially, leveling off after several months.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

Line graph showing mean change from baseline in a variable measured in liters per second (L/sec) over a 30-month period. Data points with error bars and several marked with asterisks indicate statistical significance at various months.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.